These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24910448)

  • 1. BDCA3(+)CLEC9A(+) human dendritic cell function and development.
    van der Aa E; van Montfoort N; Woltman AM
    Semin Cell Dev Biol; 2015 May; 41():39-48. PubMed ID: 24910448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
    Schreibelt G; Klinkenberg LJ; Cruz LJ; Tacken PJ; Tel J; Kreutz M; Adema GJ; Brown GD; Figdor CG; de Vries IJ
    Blood; 2012 Mar; 119(10):2284-92. PubMed ID: 22234694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDCA3 expression is associated with high IFN-λ production by CD34(+)-derived dendritic cells generated in the presence of GM-CSF, IL-4, and/or TGF-β.
    van der Aa E; van de Laar L; Janssen HL; van Montfoort N; Woltman AM
    Eur J Immunol; 2015 May; 45(5):1471-81. PubMed ID: 25616220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.
    Poulin LF; Salio M; Griessinger E; Anjos-Afonso F; Craciun L; Chen JL; Keller AM; Joffre O; Zelenay S; Nye E; Le Moine A; Faure F; Donckier V; Sancho D; Cerundolo V; Bonnet D; Reis e Sousa C
    J Exp Med; 2010 Jun; 207(6):1261-71. PubMed ID: 20479117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.
    Cohn L; Chatterjee B; Esselborn F; Smed-Sörensen A; Nakamura N; Chalouni C; Lee BC; Vandlen R; Keler T; Lauer P; Brockstedt D; Mellman I; Delamarre L
    J Exp Med; 2013 May; 210(5):1049-63. PubMed ID: 23569326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Superior Ability of Human BDCA3
    Gu FF; Zhang K; Ma LL; Liu YY; Li C; Hu Y; Yang QF; Liang JY; Zeng YL; Wang Y; Liu L
    Front Immunol; 2020; 11():1267. PubMed ID: 32655564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141
    Masterman KA; Haigh OL; Tullett KM; Leal-Rojas IM; Walpole C; Pearson FE; Cebon J; Schmidt C; O'Brien L; Rosendahl N; Daraj G; Caminschi I; Gschweng EH; Hollis RP; Kohn DB; Lahoud MH; Radford KJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset.
    Kasahara S; Clark EA
    J Leukoc Biol; 2012 Mar; 91(3):437-48. PubMed ID: 22147811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy.
    Yan Z; Wu Y; Du J; Li G; Wang S; Cao W; Zhou X; Wu C; Zhang D; Jing X; Li Y; Wang H; Gao Y; Qi Y
    Oncotarget; 2016 Jun; 7(26):40437-40450. PubMed ID: 27250027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A
    Koster BD; López González M; van den Hout MF; Turksma AW; Sluijter BJ; Molenkamp BG; van Leeuwen PA; Vosslamber S; Scheper RJ; van den Eertwegh AJ; van den Tol MP; Jordanova EJ; de Gruijl TD
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.
    Sancho D; Joffre OP; Keller AM; Rogers NC; Martínez D; Hernanz-Falcón P; Rosewell I; Reis e Sousa C
    Nature; 2009 Apr; 458(7240):899-903. PubMed ID: 19219027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
    Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
    J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.
    Zeng B; Middelberg AP; Gemiarto A; MacDonald K; Baxter AG; Talekar M; Moi D; Tullett KM; Caminschi I; Lahoud MH; Mazzieri R; Dolcetti R; Thomas R
    J Clin Invest; 2018 May; 128(5):1971-1984. PubMed ID: 29485973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation.
    Sluijter BJ; van den Hout MF; Koster BD; van Leeuwen PA; Schneiders FL; van de Ven R; Molenkamp BG; Vosslamber S; Verweij CL; van den Tol MP; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
    Cancer Immunol Res; 2015 May; 3(5):495-505. PubMed ID: 25633713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.
    Lahoud MH; Ahmet F; Kitsoulis S; Wan SS; Vremec D; Lee CN; Phipson B; Shi W; Smyth GK; Lew AM; Kato Y; Mueller SN; Davey GM; Heath WR; Shortman K; Caminschi I
    J Immunol; 2011 Jul; 187(2):842-50. PubMed ID: 21677141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
    Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K
    Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CLEC9A delivers antigen to human CD141
    Tullett KM; Leal Rojas IM; Minoda Y; Tan PS; Zhang JG; Smith C; Khanna R; Shortman K; Caminschi I; Lahoud MH; Radford KJ
    JCI Insight; 2016 May; 1(7):e87102. PubMed ID: 27699265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.
    Jongbloed SL; Kassianos AJ; McDonald KJ; Clark GJ; Ju X; Angel CE; Chen CJ; Dunbar PR; Wadley RB; Jeet V; Vulink AJ; Hart DN; Radford KJ
    J Exp Med; 2010 Jun; 207(6):1247-60. PubMed ID: 20479116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.